兴齐眼药
(300573)
| 流通市值：203.38亿 | | | 总市值：264.75亿 |
| 流通股本：9570.65万 | | | 总股本：1.25亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 480,417,942.04 | 425,355,427.88 | 432,927,979.49 | 485,537,595.56 |
| 应收票据及应收账款 | 203,333,839.04 | 208,867,044.84 | 211,043,359.49 | 159,845,424.74 |
| 其中：应收票据 | 25,789,098.73 | 12,221,446.8 | 6,127,405.12 | 16,278,703.99 |
| 应收账款 | 177,544,740.31 | 196,645,598.04 | 204,915,954.37 | 143,566,720.75 |
| 应收款项融资 | 48,769,500.62 | 44,483,947.12 | 35,840,515.25 | 33,263,397.48 |
| 预付款项 | 31,736,915.42 | 37,844,154.8 | 19,848,152.84 | 16,071,411.62 |
| 其他应收款合计 | 3,928,949.31 | 5,016,714.82 | 4,666,470.13 | 4,866,142.71 |
| 存货 | 136,025,273.52 | 124,373,298.32 | 119,985,342.16 | 124,091,395.64 |
| 其他流动资产 | 976,093.87 | 13,072.28 | 6,356,648.51 | 12,307,761.96 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 905,188,513.82 | 845,953,660.06 | 830,668,467.87 | 835,983,129.71 |
| 非流动资产: | | | | |
| 投资性房地产 | 13,000,798.61 | 11,016,403.95 | 11,167,287.27 | 11,328,572.29 |
| 固定资产 | 721,348,220.74 | 675,600,769.04 | 648,550,026.84 | 646,151,322.54 |
| 在建工程 | 106,155,765.31 | 89,041,822.9 | 89,530,338.93 | 63,046,207.48 |
| 使用权资产 | 9,847,091.39 | 11,251,274.58 | 13,387,717.35 | 13,296,012.13 |
| 无形资产 | 78,288,437.42 | 78,862,111.56 | 78,952,206.83 | 78,255,317.13 |
| 开发支出 | 109,932,100.1 | 107,949,477.74 | 104,005,062.36 | 97,752,831.72 |
| 长期待摊费用 | 8,829,214.32 | 9,809,511.78 | 7,879,173.61 | 8,383,621.61 |
| 递延所得税资产 | 38,574,731.06 | 40,830,983.08 | 39,950,014.1 | 24,351,522.95 |
| 其他非流动资产 | 32,679,863.45 | 48,054,366.43 | 48,626,816.9 | 50,608,984.64 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,118,656,222.4 | 1,072,416,721.06 | 1,042,048,644.19 | 993,174,392.49 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,023,844,736.22 | 1,918,370,381.12 | 1,872,717,112.06 | 1,829,157,522.2 |
| 流动负债: | | | | |
| 短期借款 | 70,058,333.31 | 50,000,000 | 50,000,000 | - |
| 应付票据及应付账款 | 17,565,391.85 | 12,998,697.21 | 20,197,026.79 | 17,242,515.38 |
| 应付账款 | 17,565,391.85 | 12,998,697.21 | 20,197,026.79 | 17,242,515.38 |
| 预收款项 | 214,897.61 | 106,700.67 | 200,531.22 | 221,096.42 |
| 合同负债 | 6,548,429.23 | 5,958,446.77 | 6,660,638.06 | 10,207,350.65 |
| 应付职工薪酬 | 77,597,673.93 | 77,005,031.61 | 71,166,484 | 51,001,052.54 |
| 应交税费 | 8,468,535.88 | 31,287,394.09 | 15,391,553.61 | 4,275,356.81 |
| 其他应付款合计 | 60,333,333.91 | 58,090,911.73 | 43,583,050.74 | 73,163,781.34 |
| 一年内到期的非流动负债 | 6,865,494.74 | 6,045,100.62 | 6,537,475.5 | 6,960,753.03 |
| 其他流动负债 | 12,466,628.73 | 7,415,468.77 | 5,906,292.95 | 11,595,722.96 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 260,118,719.19 | 248,907,751.47 | 219,643,052.87 | 174,667,629.13 |
| 非流动负债: | | | | |
| 租赁负债 | 2,223,863.17 | 5,760,179.03 | 5,553,814.5 | 6,226,215.07 |
| 递延收益 | 71,581,296.39 | 69,003,123.66 | 68,014,052.98 | 69,121,624.78 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 73,805,159.56 | 74,763,302.69 | 73,567,867.48 | 75,347,839.85 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 333,923,878.75 | 323,671,054.16 | 293,210,920.35 | 250,015,468.98 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 124,589,194 | 123,977,114 | 88,555,082 | 88,555,082 |
| 资本公积 | 891,009,098.6 | 854,104,183.57 | 880,354,868.7 | 859,840,957.04 |
| 盈余公积 | 59,938,445.57 | 44,277,541 | 44,277,541 | 44,277,541 |
| 未分配利润 | 614,384,119.3 | 572,340,488.39 | 566,318,700.01 | 586,468,473.18 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,689,920,857.47 | 1,594,699,326.96 | 1,579,506,191.71 | 1,579,142,053.22 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,689,920,857.47 | 1,594,699,326.96 | 1,579,506,191.71 | 1,579,142,053.22 |
| 负债和股东权益合计 | 2,023,844,736.22 | 1,918,370,381.12 | 1,872,717,112.06 | 1,829,157,522.2 |
| 公告日期 | 2024-04-19 | 2023-10-24 | 2023-08-29 | 2023-04-27 |
| 审计意见(境内) | 标准无保留意见 | | 标准无保留意见 | |